#Medical Ethics

3 AI perspectives

We Already Legalized "Designer Babies" Decades Ago — We Just Didn't Call Them That

In June 2026, Columbia University's Dieter Egli research team published a bioRxiv preprint documenting the successful application of base editing to human embryos, achieving precise correction of disease-causing genetic variants including PCSK9 and HBG1/2, with some embryos reaching 100% editing efficiency — reigniting the global designer baby debate that had largely quieted since the 2018 He Jiankui scandal. Unlike conventional CRISPR-Cas9, which physically severs both DNA strands and introduces unpredictable repair artifacts, base editing chemically converts a single nucleotide without cutting the helix, representing a qualitative leap in precision that earlier human germline editing attempts lacked entirely. Despite the technical advance, mosaicism — the uneven distribution of edits across embryonic cells — remains unresolved, and the involvement of consumer genomics company Nucleus Genomics as a funder raises legitimate questions about whether the research's ultimate destination is therapy or commercial genetic enhancement. The American Society of Gene and Cell Therapy and the International Society for Cell and Gene Therapy responded with a joint 10-year moratorium on germline editing, a move that is symbolically significant but carries zero legal enforcement power, extending a familiar pattern of paper prohibitions that failed to stop He Jiankui eight years ago. If this technology commercializes before robust international regulation is in place, the most likely outcome is access gated entirely by wealth — embedding health inequality at the DNA level and initiating what would be the first biologically encoded class divide in human history.

6/26/2026

Science

44 Namibians' DNA Just Tore the Human Origins Textbook in Half

The "Out of Africa" hypothesis — the six-decade consensus that modern humans emerged from a single ancestral population — has received its most substantive empirical challenge to date through a landmark April 2026 Nature study led by researchers at UC Davis and McGill University. Analyzing freshly sequenced genomes from 44 Indigenous Nama people of southern Africa, alongside genomic data from 290 Africans across the continent, the researchers demonstrated that Homo sapiens did not descend from a single ancestral group but rather emerged through prolonged genetic exchange among at least two or more ancient populations over hundreds of thousands of years. The study places the earliest estimated population divergence at approximately 120,000–135,000 years ago and finds that just 1–4% of genetic differences between contemporary human populations trace back to variation between ancestral stem groups — a figure that delivers a decisive empirical blow to any biological claim of racial purity or hierarchy. Independent findings from Cambridge University's Nature Genetics research and Uppsala University's ancient genome study corroborate this multi-population ancestry model, demonstrating that ancestral mixing contributed ten times more genetically to modern humans than our well-known Neanderthal admixture. Beyond overturning a foundational scientific narrative, this discovery carries sweeping implications for precision medicine, public education, and the urgent need to address the structural underrepresentation of African genomes — currently less than 3% of global genomic databases — in the research that shapes global healthcare and our understanding of human biology.

4/28/2026

Technology

A Surgeon in London Just Removed a Man's Prostate 2,400km Away — And It Took 0.06 Seconds to Cross That Distance

A London surgeon completed cancer surgery on a Gibraltar patient via robot, proving telesurgery works after 25 years of empty promises. The real question is whether this technology will serve the 5 billion people who lack surgical access, or just save the wealthy a plane ticket.

3/8/2026